Sesen Bio Inc.

NASDAQ:SESN   3:59:45 PM EDT
1.10
-0.08 (-6.78%)
4:21:58 PM EDT: $1.17 +0.07 (+6.36%)
Products

Sesen Bio Inc Says On Sept 24, Completed Final Of 3 Commercial-Scale Drug Product Process Performance Qualification Manufacturing Runs For Vicineum

Published: 09/28/2020 12:28 GMT
Eleven Biotherapeutics Inc (SESN) - Sesen Bio Inc - on Sept 24, Completed Final of 3 Commercial-scale Drug Product Process Performance Qualification Manufacturing Runs for Vicineum.
Sesen Bio Inc - All Drug Substance Ppq Batches and First of Three Drug Product Ppq Batches Met All Quality Acceptance Criteria.
Sesen Bio Inc - Testing of Second & Third Drug Product Ppq Batches Currently Underway and is Expected to Be Completed in November 2020.